The Clinical Evidence Behind NAD+ Precursors: What the Studies Actually Show

When evaluating the science of longevity and cellular metabolism, few molecules have attracted as much attention as Nicotinamide Adenine Dinucleotide (NAD+). As a fundamental coenzyme found in every living cell, it dictates everything from mitochondrial energy production to DNA repair.

However, because the NAD+ molecule itself is too large to efficiently enter cells when taken directly, scientists have turned to precursors, smaller molecular building blocks that the body can readily absorb and synthesise into NAD+.

The core premise is straightforward: NAD+ precursors reliably raise measurable NAD+ levels in human blood. That part of the biological equation is well established. What those elevated levels translate to in terms of felt, everyday benefits is supported by a smaller and more cautious body of evidence. If you find yourself asking, does NAD+ supplementation work?, it is essential to draw a clear, scientifically accurate line between biochemical proof and marketing hyperbole.

Below is an objective examination of the current NAD+ precursor clinical evidence, separating the rigorous human trial data from the theoretical promises.

What's Well Established: NAD+ Levels Actually Rise

The most definitive conclusion drawn from modern NAD+ precursor research is that these compounds successfully survive the digestive tract, enter systemic circulation, and actively convert into NAD+ within human tissues.

The Pharmacokinetics of Elevating NAD+

A first-in-humans repeat-dose trial of nicotinamide riboside (NR) combined with pterostilbene, published in npj Aging, provided clear data on this mechanism. The study found that a standard daily dose raised blood NAD+ levels by roughly 40 per cent at four weeks. Crucially, this elevation was sustained through the entire eight-week study period.

Furthermore, participants taking a double dose reached an even larger increase, settling at around 55 per cent above baseline by the same measurement point. The trial reported no serious adverse events, with mild side effects occurring at similar, statistically insignificant rates in both the treatment and placebo groups.

This established two vital facts clearly:

1. NAD+ precursor supplementation genuinely raises measurable systemic NAD+ levels.

2. Repeat daily dosing sustains that biological increase, proving that the human body does not immediately adapt to and reverse the supplementation.

The Age-Related Decline of Cellular Energy

Elevating these levels matters profoundly because NAD+ availability is not static across a human lifetime. Research examining human tissue samples across a wide age range found that NAD+ levels decline substantially from young adulthood into our later decades. This is a systemic pattern observed across multiple vital tissue types, including skin, skeletal muscle, and blood plasma, as reported in a landmark study published in PLOS ONE.

The biological reasons for this decline are twofold:

• Decreased Production: There is a natural, age-related reduction in the activity of the NAMPT enzyme, which is responsible for manufacturing NAD+ from dietary precursors via the cellular "salvage pathway."

• Increased Consumption: As we age, we accumulate cellular damage. This triggers an overactivation of repair enzymes, specifically PARPs (Poly ADP-ribose polymerases) and CD38, which aggressively consume and deplete the body’s remaining NAD+ pool to manage the damage.

Framed this way, an NAD+ precursor is less a novel, unnatural intervention and more an attempt to replace a vital raw material that the body increasingly struggles to produce and retain for itself as it advances in age.

What's More Cautiously Supported: Broader Functional Benefits

While the biochemical increase in NAD+ is undisputed, translating that cellular metric into outward physical improvements requires a careful reading of the data.

A 2025 systematic review and dose-response meta-analysis covering global NAD+ precursor research, published in Nature Metabolism, found measurable increases in NAD+ levels intricately linked to improvements in mitochondrial function markers, particularly in ageing tissue. However, the researchers were careful to note this as a strong statistical association within the studies reviewed, rather than absolute proof of a specific, guaranteed, felt outcome for every individual user.

This represents the honest state of the field: the internal biochemistry is exceptionally well demonstrated, and the downstream everyday benefit is highly plausible and supported, but it remains less definitively proven than the NAD+ increase itself.

Examining NMN Human Studies

The distinction between blood markers and physical outcomes shows up clearly in individual human trials of Nicotinamide Mononucleotide (NMN), a closely related biochemical precursor to nicotinamide riboside.

• Metabolic Function in Prediabetes: A randomised, double-blind, placebo-controlled trial of NMN in postmenopausal women with prediabetes, published in Science, measured specific functional outcomes rather than NAD+ levels alone. The researchers reported highly favourable improvements in skeletal muscle insulin sensitivity after twelve weeks of supplementation. Interestingly, this occurred without a matching improvement in overall body composition or blood pressure, demonstrating a highly targeted metabolic effect.

• Physical Function in Older Adults: A separate trial involving healthy older men, published in npj Aging, confirmed that chronic NMN supplementation reliably elevated blood NAD+ levels. The study found a modest but statistically significant improvement in walking speed and grip strength. However, it reported no significant change across several other subjective measures the researchers tracked.

Taken together, these NMN human studies illustrate the pattern running through this entire longevity category: NAD+ levels themselves respond consistently and predictably to supplementation, while functional outcomes respond selectively, showing up on specific physiological measures but not others within the exact same study.

Why This Distinction Actually Matters

Marketing for longevity supplements frequently blurs the line between "raises cellular NAD+ levels" and "will instantly make you feel more energetic and youthful." When reviewing the clinical literature, the trial evidence confidently supports the first claim, but takes a far more nuanced stance on the second.

This is absolutely not a reason to dismiss the ingredient category. Raising a genuinely relevant biological marker of youth and cellular resilience over a sustained period is a profound scientific result. It is, however, a reason to be highly sceptical of any brand promising a specific subjective transformation (such as curing fatigue overnight) as though it were equally well proven. Sensible supplementation is about long-term biological optimisation and supporting healthy ageing, not chasing acute, stimulant-like energy spikes.

The Biochemistry of a Stacked Formulation: Pterostilbene and TMG

In advanced clinical nutrition, Nicotinamide Riboside (NR) is rarely taken in absolute isolation. Formulators pair it with specific synergistic compounds to maximise cellular uptake and manage downstream metabolic byproducts. Understanding why these ingredients are combined helps explain the logic behind premium longevity stacks.

The Role of Pterostilbene (Sirtuin Activation)

Pterostilbene, the compound paired with NR in the clinical trial referenced above, is structurally similar to resveratrol (the famous compound found in red wine), but it boasts a significantly higher oral bioavailability and a longer biological half-life.

It is frequently included alongside NAD+ precursors because early laboratory research suggested it may actively support the activity of sirtuins. Sirtuins are a family of highly important protein enzymes that regulate cellular health, DNA repair, and metabolism. Crucially, sirtuins are strictly NAD-dependent; they rely on NAD+ as a necessary cofactor to carry out their work.

Pairing an NAD+ precursor (which provides the fuel) with a compound like pterostilbene (which upregulates the enzymes that use the fuel) represents highly coherent biochemical formulation logic, even though the combination itself has less independent human trial data than NR taken entirely alone.

The Role of Trimethylglycine (TMG / Betaine)

Trimethylglycine (TMG), commonly listed as betaine, plays an entirely different, highly protective role.

When the body processes and utilises NAD+, the resulting breakdown product is nicotinamide (NAM). For the body to safely excrete excess NAM and prevent it from building up and inhibiting sirtuin activity, it must process it through a specific methylation reaction. This chemical process aggressively consumes the body's store of "methyl groups."

If methyl groups are depleted, it can lead to an undesirable rise in homocysteine levels. TMG is a well-established, highly efficient methyl donor. Including it alongside an NAD+ precursor is a preventative way of supporting that downstream clearance pathway, ensuring the body's methylation cycle remains balanced. It will not appear in a clinical trial as a direct NAD-boosting ingredient because that is not its mechanism; its vital relevance sits one step further along the metabolic chain.

FAQ

Does taking a NAD+ precursor guarantee I'll feel more energetic?

No. The trial evidence confidently shows that systemic NAD+ levels rise and stay elevated with consistent use. While subjective energy improvements are entirely plausible, given NAD+'s fundamental role in mitochondrial ATP (energy) production, they are less rigorously proven in human trials than the objective cellular NAD+ increase itself.

How long does it take for NAD+ levels to rise with supplementation?

Clinical data, such as the trial referenced above, demonstrates a measurable increase in blood NAD+ levels within four weeks of taking a standard daily dose, with that elevation sustained through at least eight weeks of continued use.

Is nicotinamide riboside better studied than NMN?

When looking strictly at nicotinamide riboside clinical trials, NR currently possesses a slightly longer and more established track record of published human data. However, NMN human studies have grown considerably in volume and rigour in recent years. At present, neither compound possesses a vast body of long-term, multi-decade human trial data.

Are NAD+ precursors safe for long-term use?

The human trials conducted to date, which generally run for periods of weeks or months rather than years, have not raised any significant safety concerns or serious adverse events. However, genuinely long-term data spanning continuous, multi-year use is still an evolving area of science across this entire nutritional category.

Does combining NR with pterostilbene do more than NR alone?

The specific combination of NR and pterostilbene has its own dedicated human trial data showing successful, sustained NAD+ elevation. Because pterostilbene theoretically supports sirtuin activity (the very enzymes that consume NAD+ for cellular repair), it provides a meaningful, synergistic point in its favour compared to relying solely on studies of NR in isolation.

Do NMN trials show the same pattern as NR trials?

Broadly, yes. Human trials of NMN, similarly to those of NR, consistently show that blood NAD+ levels successfully rise with oral supplementation. Functional physical outcomes are more mixed; some trials report specific, targeted benefits such as improved muscle insulin sensitivity or increased grip strength, while others find no statistically significant changes across other physiological measures tracked within the exact same study.

Why is trimethylglycine (TMG) included alongside NR and pterostilbene?

TMG, also known as betaine, directly supports the methylation pathway. The body uses this pathway to process and excrete nicotinamide (NAM) once NR has donated its value to the cellular NAD+ pool. TMG acts as a methyl donor, included specifically to support that necessary downstream clearance step and prevent methyl depletion, rather than to raise NAD+ levels directly.

When analysing the data objectively, NAD+ precursor clinical evidence demonstrates that this is one of the more genuinely evidenced areas of the modern longevity supplement category for its primary, measurable effect: successfully raising NAD+ levels in human tissue. However, the broader, subjective lifestyle promises built on top of that specific biochemical finding always deserve a more rigorous, sceptical read.

For those looking for a scientifically coherent stack, our formulated longevity complex, built meticulously around the NR, TMG, and pterostilbene combination referenced in the trials above, is available at our Longevity+ formulation.

Additionally, if you are currently weighing this biological intervention against other options for your healthy ageing programme, Creatine, NMN or a Stack: How to Choose the Right Format for Your Goals is highly recommended reading to ensure your supplementation aligns with your exact physiological goals.